Accumulating evidence suggest LOXL4 an oncoprotein in several tumors, such as hepatocellular carcinoma (Li et al., 2019), lung cancer (Zhang et al., 2019) and breast cancer (Choi et al., 2017). Here, LOXL4 is linked to breast cancer.